Chemed Corporation Financial Statements (CHE)
|
|
|
|
Report date
|
|
|
28.02.2022 |
27.02.2023 |
29.02.2024 |
28.02.2025 |
27.02.2026 |
|
28.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
2 139 |
2 135 |
2 264 |
2 431 |
2 530 |
|
2 541 |
|
Operating Income, bln rub |
|
|
343.0 |
343.5 |
340.6 |
366.5 |
338.2 |
|
328.1 |
|
EBITDA, bln rub |
? |
|
411.2 |
393.4 |
414.3 |
464.3 |
422.4 |
|
413.3 |
|
Net profit, bln rub |
? |
|
268.6 |
249.6 |
272.5 |
302.0 |
265.2 |
|
259.8 |
|
|
OCF, bln rub |
? |
|
308.6 |
309.9 |
330.3 |
417.5 |
388.3 |
|
443.7 |
|
CAPEX, bln rub |
? |
|
58.7 |
57.3 |
56.9 |
49.5 |
62.8 |
|
66.6 |
|
FCF, bln rub |
? |
|
249.9 |
252.6 |
273.4 |
368.0 |
325.5 |
|
377.1 |
|
Dividend payout, bln rub
|
|
|
22.0 |
22.0 |
23.5 |
27.1 |
31.7 |
|
32.5 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
8.20% |
8.82% |
8.62% |
8.97% |
11.9% |
|
12.5% |
|
|
OPEX, bln rub |
|
|
426.8 |
421.6 |
458.2 |
487.9 |
417.2 |
|
442.2 |
|
Cost of production, bln rub |
|
|
1 369 |
1 370 |
1 466 |
1 577 |
1 772 |
|
1 770 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
1.87 |
4.58 |
3.11 |
1.78 |
1.75 |
|
3.48 |
|
|
Assets, bln rub |
|
|
1 343 |
1 442 |
1 668 |
1 669 |
1 640 |
|
1 536 |
|
Net Assets, bln rub |
? |
|
623.3 |
798.7 |
1 108 |
1 119 |
979.4 |
|
848.0 |
|
Debt, bln rub |
|
|
323.5 |
247.0 |
155.1 |
140.8 |
154.8 |
|
236.9 |
|
Cash, bln rub |
|
|
32.9 |
74.1 |
264.0 |
178.4 |
74.5 |
|
16.9 |
|
Net debt, bln rub |
|
|
290.6 |
172.9 |
-108.8 |
-37.5 |
80.2 |
|
220.1 |
|
|
Ordinary share price, rub |
|
|
529.0 |
510.4 |
584.8 |
529.8 |
427.9 |
|
564.5 |
|
Number of ordinary shares, mln |
|
|
15.7 |
14.9 |
15.1 |
15.0 |
14.4 |
|
13.7 |
|
|
Market cap, bln rub |
|
|
8 291 |
7 620 |
8 800 |
7 960 |
6 160 |
|
7 719 |
|
EV, bln rub |
? |
|
8 581 |
7 793 |
8 692 |
7 922 |
6 241 |
|
7 939 |
|
Book value, bln rub |
|
|
-63 |
118 |
433 |
360 |
230 |
|
80 |
|
|
EPS, rub |
? |
|
17.1 |
16.7 |
18.1 |
20.1 |
18.4 |
|
19.0 |
|
FCF/share, rub |
|
|
15.9 |
16.9 |
18.2 |
24.5 |
22.6 |
|
27.6 |
|
BV/share, rub |
|
|
-4.05 |
7.88 |
28.7 |
24.0 |
15.9 |
|
5.86 |
|
|
EBITDA margin, % |
? |
|
19.2% |
18.4% |
18.3% |
19.1% |
16.7% |
|
16.3% |
|
Net margin, % |
? |
|
12.6% |
11.7% |
12.0% |
12.4% |
10.5% |
|
10.2% |
|
FCF yield, % |
? |
|
3.01% |
3.31% |
3.11% |
4.62% |
5.28% |
|
4.89% |
|
ROE, % |
? |
|
43.1% |
31.3% |
24.6% |
27.0% |
27.1% |
|
30.6% |
|
ROA, % |
? |
|
20.0% |
17.3% |
16.3% |
18.1% |
16.2% |
|
16.9% |
|
|
P/E |
? |
|
30.9 |
30.5 |
32.3 |
26.4 |
23.2 |
|
29.7 |
|
P/FCF |
|
|
33.2 |
30.2 |
32.2 |
21.6 |
18.9 |
|
20.5 |
|
P/S |
? |
|
3.88 |
3.57 |
3.89 |
3.27 |
2.43 |
|
3.04 |
|
P/BV |
? |
|
-130.7 |
64.7 |
20.3 |
22.1 |
26.8 |
|
96.4 |
|
EV/EBITDA |
? |
|
20.9 |
19.8 |
21.0 |
17.1 |
14.8 |
|
19.2 |
|
Debt/EBITDA |
|
|
0.71 |
0.44 |
-0.26 |
-0.08 |
0.19 |
|
0.53 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
2.74% |
2.69% |
2.51% |
2.04% |
2.48% |
|
2.62% |
|
| Chemed Corporation shareholders |
